Sort
10,766 grants matching “checkpoint inhibitor”
In Vivo Regulation and Inhibition of Ribonucleotide Reductase
$314,155Mingxia Huang · University Of Colorado Denver · R01 · FY2009 · CA
Project 1
$314,071Ann G Schwartz · Wayne State University · P20 · FY2021 · CA
Targeting Stat3 to Improve Immunotherapy
$314,070Hua E Yu · Beckman Research Institute/City Of Hope · R01 · FY2013 · CA
Genetics of Meiosis and Recombination in Mice
$314,062John C Schimenti · Cornell University · R01 · FY2013 · GM
Project 3: The Functional Contribution of Tumor Immunity in PDAC
$314,011Raghu Kalluri · University Of Tx Md Anderson Can Ctr · P01 · FY2019 · CA
Regulation of the Anaphase-Promoting Complex by the Spindle Checkpoint
$314,000Hongtao Yu · Ut Southwestern Medical Center · R01 · FY2006 · GM
Genetics of Meiosis and Recombination in Mice
$313,893John C Schimenti · Cornell University · R01 · FY2014 · GM
Project 1 - Integrating targeted and immune therapies for BRAF mutant colorectal cancer
$313,875Ryan Bruce Corcoran · Dana-Farber Cancer Inst · P50 · FY2023 · CA
Genetics of Meiosis and Recombination in Mice
$313,719John C Schimenti · Cornell University · R01 · FY2015 · GM
Development of a small molecule activator of integrin cell adhesion to enhance therapeutic responses to checkpoint blockade in cancer
$313,705Upendra Marathi · 7 Hills Pharma, Llc · R41 · FY2016 · CA
Genetics of Meiosis and Recombination in Mice
$313,540John C Schimenti · Cornell University · R01 · FY2016 · GM
Effects of ATR-CHK1 inhibition on genome stability and cancer progression
$313,494Eric J Brown · University Of Pennsylvania · R01 · FY2019 · CA
The role of ECM-mediated mechanosignaling on regional immunosuppression in GBM
$313,293Joseph Chen · University Of Louisville · P20 · FY2025 · GM
Suppression of translocations by RecQ-like DNA helicases
$313,276Kristina Schmidt · University Of South Florida · R01 · FY2011 · GM
Project 2
$313,265Tomas Kirchhoff · New York University School Of Medicine · P50 · FY2025 · CA
Applying deep learning to predict T cell receptor binding specificity of neoantigens and response to checkpoint inhibitors
$313,223Tao Wang · Ut Southwestern Medical Center · R01 · FY2025 · CA
Mechanisms of immunomodulation with epigenetic therapy
$313,219Nilofer S. Azad · Johns Hopkins University · P01 · FY2021 · CA
Mechanisms of immunomodulation with epigenetic therapy
$313,219Nilofer S. Azad · Johns Hopkins University · P01 · FY2025 · CA
Project-Race and ancestry as predictors of the tumor immune microenvironment and response to immunotherapy
$313,039Elad Ziv · University Of California, San Francisco · P20 · FY2024 · CA
Identifying Inhibitors of the APC/C Using Yeast Mutants
$313,024University Of Virginia Charlottesville · R01 · FY2003 · CA
Mechanisms of apoptosis regulation which impede cancer cell death in lung cancer
$312,939King Kwong · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
STINGing GBM: A First-in- Man Clinical Trial in Surgical Resectable Recurrent GBM
$312,874Amy Beth Heimberger · Northwestern University At Chicago · P50 · FY2024 · CA
Employing Humanized Microbiome Mice to Understand Immune Activation and Translational Therapeutic Potential in Glioblastoma
$312,852Braden Cox McFarland · University Of Alabama At Birmingham · R01 · FY2024 · CA
Reprogramming the TME for immunogenic antigen-presentation
$312,717David H Munn · Augusta University · R01 · FY2024 · CA
P34CDC2 AND CELL CYCLE CONTROL
$312,283Washington University · R01 · FY2002 · GM